1. Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene. Issue 3 (3rd June 2023) Authors: Boileau, Marie; Descarpentries, Clotilde; Delzenne, Guillaume; Trentesaux, Victorine; Greliak, Anna; Jamme, Philippe; Marchetti, Philippe; Mortier, Laurent Journal: Melanoma research Issue: Volume 33:Issue 3(2023) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma. (August 2020) Authors: Baldacci, Simon; Grégoire, Valérie; Patrucco, Enrico; Chiarle, Roberto; Jamme, Philippe; Wasielewski, Eric; Descarpentries, Clotilde; Copin, Marie-Christine; Awad, Mark M; Cortot, Alexis B Journal: Lung cancer Issue: Volume 146(2020) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab. (May 2021) Authors: Hober, Candice; Jamme, Philippe; Desmedt, Eve; Greliak, Anna; Mortier, Laurent Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ipilimumab in anti-PD1 refractory metastatic melanoma: a report of eight cases. Issue 2 (April 2016) Authors: Jacobsoone-Ulrich, Aurélie; Jamme, Philippe; Alkeraye, Salim; Dzwiniel, Véronique; Faure, Emmanuel; Templier, Carole; Mortier, Laurent Journal: Melanoma research Issue: Volume 26:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica. Issue 6 (December 2018) Authors: Mahjoubi, Linda; Cecchi, Fabiola; Massard, Christophe; Calabro, Fabio; Gazzah, Anas; Bahleda, Rastislav; Jamme, Philippe; Gelli, Maximiliano; Goere, Diane; Lacroix, Ludovic; Adam, Julien; Heukamp, Lukas; Trenta, Patrizia; Hembrough, Todd; Soria, Jean-Charles; Sternberg, Cora; Ducreux, Michel Journal: Tumori Issue: Volume 104:Issue 6(2018) Page Start: NP38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma. (23rd March 2022) Authors: Oberlé, Marion; Jamme, Philippe; Mansard, Sandrine; Machet, Laurent; Hervieu, Alice; Kramkimel, Nora; Greliak, Anna; Jarrousse, Anne Sophie; Derangère, Valentin; Dudoignon, David; Descarpentries, Clotilde; Mortier, Laurent Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial. (December 2022) Authors: Véron, Marie; Chevret, Sylvie; Grob, Jean-Jacques; Beylot-Barry, Marie; Saiag, Philippe; Fléchon, Aude; You, Benoit; Maubec, Eve; Jouary, Thomas; Toulemonde, Elise; Jamme, Philippe; Gambotti, Laëtitia; Lamrani-Ghaouti, Assia; Dupuy, Alain; Lebbe, Céleste; Seguin, Nicole Basset; Houede, Nadine; Le... Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Unexpected cure of a toxic nodule in a multinodular goiter induced by immune checkpoint inhibitors: a case report. Issue 4 (23rd June 2022) Authors: Dupuis, Hippolyte; Merlen, Emilie; Jannin, Arnaud; Jamme, Philippe; Fagart, Alexandre; Vantyghem, Marie-Christine; Ladsous, Miriam Journal: European thyroid journal Issue: Volume 11:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗